Sylwia Czekalska

A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs

Dorota Link-Lenczowska, Niels Pallisgaard, Sabrina Cordua et al. · Annals of Hematology · 2018 · 60 citations · Full text

Medicine, Molecular Medicine, Pathology +14

Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia

Alicja Nowakowska−Kopera, Tomasz Sacha, Izabela Florek et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 22 citations · Full text

Medicine, Hematology, Oncology +17

ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis

Tomasz Sacha, Andreas Hochhaus, Benjamin Hanfstein et al. · Leukemia Research · 2003 · 18 citations · Full text

Medicine, Hematology, Molecular Biology +13

The Gain-of-Function JAK2 V617F Mutation Shifts the Phenotype of Essential Thrombocythemia and Chronic Idiopathic Myelofibrosis to More "Erythremic" and Less "Thrombocythemic": A Molecular, Histologic, and Clinical Study

Zbigniew Rudzki, Tomasz Sacha, Anastazja Stój et al. · International Journal of Hematology · 2007 · 16 citations

Medicine, Genetics, Hematology +9

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen

Marta Libura, Emilia Białopiotrowicz, Sebastian Giebel et al. · Scientific Reports · 2021 · 13 citations · Full text

Medicine, Genetics, Molecular Genetics +15